TFO Wealth Partners’s Biogen BIIB Stock Holding History

TFO Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3	Closed	-$647	–	141
2024 Q1	$647	Sell	3 -1	-25%	-$234	﹤0.01%	215
2023 Q4	$1.03K	Sell	4 -2	-33%	-$491	﹤0.01%	193
2023 Q3	$1.71K	Buy	6 +3	+100%	+$802	﹤0.01%	220
2023 Q2	$855	Hold	3	–	–	﹤0.01%	218
2023 Q1	$834	Hold	3	–	–	﹤0.01%	183
2022 Q4	$34	Buy	+3	New	+$847	﹤0.01%	881

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TFO Wealth Partners's BIIB Position: Q2 2024 in Review

TFO Wealth Partners sold out of Biogen (BIIB) in Q2 2024, closing a stake of 3 shares — an estimated $647 sold.

TFO Wealth Partners first reported a position in BIIB in Q4 2022 and held it in 6 quarters. The position peaked at $1.71K in Q3 2023. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

TFO Wealth Partners reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
TFO Wealth Partners sold 3 Biogen shares in Q2 2024, an estimated $647.
TFO Wealth Partners first reported a position in Biogen in Q4 2022 and held it in 6 quarters.
TFO Wealth Partners's Biogen position peaked at $1.71K in Q3 2023.
943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on TFO Wealth Partners's 13F filing for Q2 2024, filed 15 Aug 2024.